Effect of Estrogen Therapy on TNF-α and iNOS Gene Expression in Spinal Cord Injury Model.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Acta Medica Iranica

• Publication date

  2016-06-08

• Fields of study

  Medicine

• Identifiers
  PMID 27309476
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation and Regulation of NLRP3 Inflammasome by Intrathecal Application of SDF-1a in a Spinal Cord Injury Model

  2015cited by this paper
• Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways.

  2008cited by this paper
• Neuroprotective effects of estrogen and selective estrogen receptor modulators begin at the plasma membrane.

  2007cited by this paper
• Cross-talk between nuclear receptors and nuclear factor κB

  2006cited by this paper
• Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats

  2005cited by this paper
• Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis

  2004cited by this paper
• Systemic Administration of 17β-Estradiol Reduces Apoptotic Cell Death and Improves Functional Recovery following Traumatic Spinal Cord Injury in Rats

  2004cited by this paper
• A Global Perspective on Spinal Cord Injury Epidemiology

  2004cited by this paper
• Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis.

  2004cited by this paper
• Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury.

  2004cited by this paper
• Minocycline Treatment Reduces Delayed Oligodendrocyte Death, Attenuates Axonal Dieback, and Improves Functional Outcome after Spinal Cord Injury

  2004cited by this paper
• Regulation of the lipopolysaccharide signal transduction pathway by 17beta-estradiol in macrophage cells.

  2004cited by this paper
• 17Beta-estradiol treatment profoundly down-regulates gene expression in spinal cord tissue in mice protected from experimental autoimmune encephalomyelitis.

  2003cited by this paper
• Estrogen receptor-α mediates the brain antiinflammatory activity of estradiol

  2003cited by this paper
• Low-Dose Estrogen Therapy Ameliorates Experimental Autoimmune Encephalomyelitis in Two Different Inbred Mouse Strains1

  2001cited by this paper
• Estrogen Treatment Down-Regulates TNF-α Production and Reduces the Severity of Experimental Autoimmune Encephalomyelitis in Cytokine Knockout Mice1

  2001cited by this paper
• Reduction in infarct size by local estrogen does not prevent autonomic dysfunction after stroke.

  2001cited by this paper
• Association of serum estrogen level and ischemic neuroprotection in female rats.

  2001cited by this paper
• Epidemiology, demographics, and pathophysiology of acute spinal cord injury.

  2001cited by this paper
• Estrogen as a Neuroprotectant in Stroke

  2000cited by this paper
• Antiinflammatory effects of estrogen on microglial activation.

  2000cited by this paper
• Antioxidant activities of estrogens against aqueous and lipophilic radicals; differences between phenol and catechol estrogens.

  2000cited by this paper
• Sequential mRNA Expression for Immediate Early Genes, Cytokines, and Neurotrophins in Spinal Cord Injury

  2000cited by this paper
• Role of tumor necrosis factor-α in neuronal and glial apoptosis after spinal cord injury

  2000influential reference
• The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties.

  1999cited by this paper
• Calcium influx and activation of calpain I mediate acute reactive gliosis in injured spinal cord.

  1999cited by this paper
• Early neuronal expression of tumor necrosis factor-alpha after experimental brain injury contributes to neurological impairment.

  1999cited by this paper
• Methylprednisolone inhibition of TNF-alpha expression and NF-kB activation after spinal cord injury in rats.

  1998cited by this paper
• Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis.

  1998cited by this paper
• Traumatic Spinal Cord Injury Induces Nuclear Factor-κB Activation

  1998cited by this paper
• Increase of interleukin-1β mRNA and protein in the spinal cord following experimental traumatic injury in the rat

  1997cited by this paper
• Expression of Pro‐Inflammatory Cytokine and Chemokine mRNA Upon Experimental Spinal Cord Injury in Mouse: an In Situ Hybridization Study

  1997cited by this paper
• Production of tumor necrosis factor in spinal cord following traumatic injury in rats.

  1996cited by this paper
• Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly.

  1996cited by this paper
• Cytokines and their receptors in the central nervous system: physiology, pharmacology, and pathology.

  1996influential reference
• Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors

  1995cited by this paper
• Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis

  1995cited by this paper
• Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.

  1995cited by this paper
• Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice.

  1994cited by this paper
• Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression.

  1994cited by this paper
• TNF receptors TR60 and TR80 can mediate apoptosis via induction of distinct signal pathways.

  1994cited by this paper
• Sequential expression of c-fos protooncogene, TNF-alpha, and dynorphin genes in spinal cord following experimental traumatic injury.

  1994cited by this paper
• Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action.

  1992cited by this paper
• Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study.

  1992cited by this paper
• Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

  1991cited by this paper
• Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1.

  1991cited by this paper
• A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study.

  1991cited by this paper
• Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms.

  1991cited by this paper
• Methylprednisolone in Spinal Cord Injury: The Possible Mechanism of Action

  1990cited by this paper
• Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus.

  1989cited by this paper
• Microvascular perfusion and metabolism in injured spinal cord after methylprednisolone treatment.

  1982cited by this paper
• SURGERY OF EXPERIMENTAL LESION OF SPINAL CORD EQUIVALENT TO CRUSH INJURY OF FRACTURE DISLOCATION OF SPINAL COLUMN: A PRELIMINARY REPORT

  1911cited by this paper

• Regulatory effect of inflammatory mediators in spinal cord injury

  2025cites this paper
• Injectable thermosensitive hydrogel system based on hyaluronic acid and methylcellulose for the synergistic therapy of traumatic spinal cord injury.

  2025cites this paper
• Targeted Therapy of Spinal Cord Injury: Inhibition of Apoptosis Is a Promising Therapeutic Strategy

  2023cites this paper
• The NF-κB Pathway: a Focus on Inflammatory Responses in Spinal Cord Injury

  2023cites this paper
• Rodent Models of Spinal Cord Injury: From Pathology to Application

  2022cites this paper
• Subventricular zone-derived extracellular vesicles promote functional recovery in rat model of spinal cord injury by inhibition of NLRP3 inflammasome complex formation

  2020cites this paper
• Down‐regulation of microRNA‐34c‐5p alleviates neuropathic pain via the SIRT1/STAT3 signaling pathway in rat models of chronic constriction injury of sciatic nerve

  2020cites this paper
• Modulating Pro-inflammatory Cytokines, Tissue Damage Magnitude, and Motor Deficit in Spinal Cord Injury with Subventricular Zone-Derived Extracellular Vesicles

  2019cites this paper
• Schwann cell transplantation exerts neuroprotective roles in rat model of spinal cord injury by combating inflammasome activation and improving motor recovery and remyelination

  2019cites this paper
• Effects of Sirtuin 1 on microglia in spinal cord injury: involvement of Wnt/β-catenin signaling pathway.

  2019cites this paper
• l-Theanine improves functional recovery after traumatic spinal cord injury in rats.

  2019cites this paper
• Stem cells from human apical papilla decrease neuro-inflammation and stimulate oligodendrocyte progenitor differentiation via activin-A secretion

  2018cites this paper
• Valproate reduces neuroinflammation and neuronal death in a rat chronic constriction injury model

  2018cites this paper
• THE EFFECT OF ESTROGEN RECEPTOR AGONISTS ON PANCREATICOBILIARY DUCT LIGATION INDUCED EXPERIMENTAL ACUTE PANCREATITIS

  2018cites this paper
• Lipid Peroxidation and Its Role in the Expression of NLRP1a and NLRP3 Genes in Testicular Tissue of Male Rats: A Model of Spinal Cord Injury

  2018cites this paper
• [Neuroprotective effects and mechanism of saikosaponin A on acute spinal cord injury in rats].

  2017cites this paper
• An Agonist of the Protective Factor SIRT1 Improves Functional Recovery and Promotes Neuronal Survival by Attenuating Inflammation after Spinal Cord Injury

  2017cites this paper
• Nanofiber Scaffolds as Drug Delivery Systems to Bridge Spinal Cord Injury

  2017cites this paper
• Hormonal therapy in traumatic spinal cord injury.

  2017cites this paper
• Multiple organ dysfunction and systemic inflammation after spinal cord injury: a complex relationship

  2016cites this paper